Search research articles
Contact Us
Filters
Showing results (51-60 of 111) with videos related to
Page
of 12
Sort By:
Transfusion
|
October 19, 2002
Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population
R Y Dodd, E P Notari, S L Stramer
Clinical Microbiology Reviews
|
July 1, 1994
Transfusion-associated bacterial sepsis
S J Wagner, L I Friedman, R Y Dodd
Blood Cells
|
January 1, 1992
Factors influencing virus inactivation and retention of platelet properties following treatment with aminomethyltrimethylpsoralen and ultraviolet A light
G Moroff, S Wagner, L Benade, et al.
Infection Control and Hospital Epidemiology
|
August 1, 1988
The American Red Cross experience with HTLV-I
R Y Dodd, C T Fang, A E Williams
Transfusion
|
May 12, 2006
Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV-I and -II confirmatory algorithm, 1999 to 2004
S L Stramer, G A Foster, R Y Dodd
Transfusion Medicine Reviews
|
January 1, 1991
Approaches to the reduction of viral infectivity in cellular blood components and single donor plasma
S J Wagner, L I Friedman, R Y Dodd
Transfusion
|
January 31, 2006
Self-reported symptoms associated with West Nile virus infection in RNA-positive blood donors
S L Orton, S L Stramer, R Y Dodd
Transfusion
|
April 24, 2004
Current impact of the confidential unit exclusion option
S Zou, E P Notari, F Musavi, et al.
Journal of Immunological Methods
|
January 1, 1978
A highly sensitive radioimmunoassay technique for subtyping the antibody to hepatitis B surface antigen
C T Fang, N Nath, H Berberian, et al.
Journal of Virological Methods
|
June 1, 1981
A modified technique for the detection of hepatitis B virus-specific DNA polymerase
C T Fang, N Nath, M Pielech, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 111) with videos related to
Sort By:
Page
of 12
Transfusion
|
October 19, 2002
Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population
R Y Dodd, E P Notari, S L Stramer
Clinical Microbiology Reviews
|
July 1, 1994
Transfusion-associated bacterial sepsis
S J Wagner, L I Friedman, R Y Dodd
Blood Cells
|
January 1, 1992
Factors influencing virus inactivation and retention of platelet properties following treatment with aminomethyltrimethylpsoralen and ultraviolet A light
G Moroff, S Wagner, L Benade, et al.
Infection Control and Hospital Epidemiology
|
August 1, 1988
The American Red Cross experience with HTLV-I
R Y Dodd, C T Fang, A E Williams
Transfusion
|
May 12, 2006
Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV-I and -II confirmatory algorithm, 1999 to 2004
S L Stramer, G A Foster, R Y Dodd
Transfusion Medicine Reviews
|
January 1, 1991
Approaches to the reduction of viral infectivity in cellular blood components and single donor plasma
S J Wagner, L I Friedman, R Y Dodd
Transfusion
|
January 31, 2006
Self-reported symptoms associated with West Nile virus infection in RNA-positive blood donors
S L Orton, S L Stramer, R Y Dodd
Transfusion
|
April 24, 2004
Current impact of the confidential unit exclusion option
S Zou, E P Notari, F Musavi, et al.
Journal of Immunological Methods
|
January 1, 1978
A highly sensitive radioimmunoassay technique for subtyping the antibody to hepatitis B surface antigen
C T Fang, N Nath, H Berberian, et al.
Journal of Virological Methods
|
June 1, 1981
A modified technique for the detection of hepatitis B virus-specific DNA polymerase
C T Fang, N Nath, M Pielech, et al.
Page
of 12